First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 13, 2024

Meridian Bioscience Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Cash from Financing Activities Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Cash from Financing Activities
-$34.3m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Cash from Financing Activities
$116m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Cash from Financing Activities
-$338m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
-4%
Align Technology Inc
NASDAQ:ALGN
Cash from Financing Activities
-$598.3m
CAGR 3-Years
-129%
CAGR 5-Years
-13%
CAGR 10-Years
-34%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Financing Activities
-$21.2m
CAGR 3-Years
26%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is Meridian Bioscience Inc's Cash from Financing Activities?
Cash from Financing Activities
-34.3m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Cash from Financing Activities amounts to -34.3m USD.

What is Meridian Bioscience Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-4%

Over the last year, the Cash from Financing Activities growth was -10%.